Literature DB >> 34301780

Performance Characteristics of the Biograph Vision Quadra PET/CT System with a Long Axial Field of View Using the NEMA NU 2-2018 Standard.

George A Prenosil1, Hasan Sari2,3, Markus Fürstner2, Ali Afshar-Oromieh2, Kuangyu Shi2, Axel Rominger2, Michael Hentschel2.   

Abstract

Our purpose was to evaluate the performance of the Biograph Vision Quadra PET/CT system. This new system is based on the Biograph Vision 600, using the same silicon photomultiplier-based detectors with 3.2 × 3.2 × 20 mm lutetium-oxoorthosilicate crystals. The 32 detector rings of the Quadra provide a 4-fold larger axial field of view (AFOV) of 106 cm, enabling imaging of major organs in 1 bed position.
Methods: The physical performance of the scanner was evaluated according to the National Electrical Manufacturers Association NU 2-2018 standard, with additional experiments to characterize energy resolution. Image quality was assessed with foreground-to-background ratios of 4:1 and 8:1. Additionally, a clinical 18F-FDG PET study was reconstructed with varying frame durations. In all experiments, data were acquired using the maximum ring distance of 322 crystals (MRD 322), whereas image reconstructions could be performed with a maximum ring distance of only 85 crystals (MRD 85).
Results: The spatial resolution at full width at half maximum in the radial, tangential, and axial directions was 3.3, 3.4, and 3.8 mm, respectively. The sensitivity was 83 cps/kBq for MRD 85 and 176 cps/kBq for MRD 322. The noise-equivalent count rates (NECRs) at peak were 1,613 kcps for MRD 85 and 2,956 kcps for MRD 322, both at 27.49 kBq/mL. The respective scatter fractions at peak NECR equaled 36% and 37%. The time-of-flight resolution at peak NECR was 228 ps for MRD 85 and 230 ps for MRD 322. Image contrast recovery ranged from 69.6% to 86.9% for 4:1 contrast ratios and from 77.7% to 92.6% for 8:1 contrast ratios reconstructed using point-spread function time of flight with 8 iterations and 5 subsets. Thirty-second frames provided readable lesion detectability and acceptable noise levels in clinical images.
Conclusion: The Biograph Vision Quadra PET/CT device has spatial and time resolution similar to those of the Biograph Vision 600 but exhibits improved sensitivity and NECR because of its extended AFOV. The reported spatial resolution, time resolution, and sensitivity make it a competitive new device in the class of PET scanners with an extended AFOV.
© 2022 by the Society of Nuclear Medicine and Molecular Imaging.

Entities:  

Keywords:  NEMA; acceptance test; digital PET; long field of view; total-body

Mesh:

Substances:

Year:  2021        PMID: 34301780     DOI: 10.2967/jnumed.121.261972

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  15 in total

1.  Expert consensus on oncological [18F]FDG total-body PET/CT imaging (version 1).

Authors:  Haojun Yu; Yushen Gu; Wei Fan; Yongju Gao; Meiyun Wang; Xiaohua Zhu; Zhifang Wu; Jianjun Liu; Biao Li; Hubing Wu; Zhaoping Cheng; Shuxia Wang; Yiqiu Zhang; Baixuan Xu; Sijin Li; Hongcheng Shi
Journal:  Eur Radiol       Date:  2022-06-25       Impact factor: 5.315

2.  Quantitative evaluation of a deep learning-based framework to generate whole-body attenuation maps using LSO background radiation in long axial FOV PET scanners.

Authors:  Hasan Sari; Mohammadreza Teimoorisichani; Clemens Mingels; Ian Alberts; Vladimir Panin; Deepak Bharkhada; Song Xue; George Prenosil; Kuangyu Shi; Maurizio Conti; Axel Rominger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-07-19       Impact factor: 10.057

3.  An encoder-decoder network for direct image reconstruction on sinograms of a long axial field of view PET.

Authors:  Ruiyao Ma; Jiaxi Hu; Hasan Sari; Song Xue; Clemens Mingels; Marco Viscione; Venkata Sai Sundar Kandarpa; Wei Bo Li; Dimitris Visvikis; Rui Qiu; Axel Rominger; Junli Li; Kuangyu Shi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-07-11       Impact factor: 10.057

4.  The potential of a medium-cost long axial FOV PET system for nuclear medicine departments.

Authors:  Stefaan Vandenberghe; Nicolas A Karakatsanis; Maya Abi Akl; Jens Maebe; Suleman Surti; Rudi A Dierckx; Daniel A Pryma; Sadek A Nehmeh; Othmane Bouhali; Joel S Karp
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-09-30       Impact factor: 10.057

5.  Data-driven, energy-based method for estimation of scattered events in positron emission tomography.

Authors:  Nikos Efthimiou; Joel S Karp; Suleman Surti
Journal:  Phys Med Biol       Date:  2022-04-21       Impact factor: 4.174

6.  Radioembolization Dosimetry with Total-Body 90Y PET.

Authors:  Gustavo Costa; Benjamin Spencer; Negar Omidvari; Cameron Foster; Michael Rusnak; Heather Hunt; Denise T Caudle; Rex T Pillai; Catherine Tram Vu; Emilie Roncali
Journal:  J Nucl Med       Date:  2021-11-18       Impact factor: 11.082

Review 7.  Influences on PET Quantification and Interpretation.

Authors:  Julian M M Rogasch; Frank Hofheinz; Lutz van Heek; Conrad-Amadeus Voltin; Ronald Boellaard; Carsten Kobe
Journal:  Diagnostics (Basel)       Date:  2022-02-10

8.  Abbreviated scan protocols to capture 18F-FDG kinetics for long axial FOV PET scanners.

Authors:  Varsha Viswanath; Hasan Sari; Austin R Pantel; Maurizio Conti; Margaret E Daube-Witherspoon; Clemens Mingels; Ian Alberts; Lars Eriksson; Kuangyu Shi; Axel Rominger; Joel S Karp
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-03-12       Impact factor: 10.057

9.  Radioactivity and Space Range of Ultra-Low-Activity for in vivo Off-line PET Verification of Proton and Carbon Ion Beam-A Phantom Study.

Authors:  Fuquan Zhang; Junyu Zhang; Yan Lu; Yixiangzi Sheng; Yun Sun; Jiangang Zhang; Jingyi Cheng; Rong Zhou
Journal:  Front Public Health       Date:  2021-12-06

10.  EARL compliance measurements on the biograph vision Quadra PET/CT system with a long axial field of view.

Authors:  George A Prenosil; Michael Hentschel; Thilo Weitzel; Hasan Sari; Kuangyu Shi; Ali Afshar-Oromieh; Axel Rominger
Journal:  EJNMMI Phys       Date:  2022-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.